Compass Group LLC Procaps Group, S.A. Transaction History

Compass Group LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$3.5 - $4.31 $4,987 - $6,141	-1,425 Reduced 36.0%	2,533 $9,000
Q2 2023 Aug 14, 2023	SELL	$3.84 - $5.04 $539,174 - $707,666	-140,410 Reduced 97.26%	3,958 $17,000
Q1 2023 May 12, 2023	SELL	$3.68 - $5.27 $1.45 Million - $2.08 Million	-395,364 Reduced 73.25%	144,368 $651,000
Q4 2022 Feb 14, 2023	SELL	$4.89 - $7.37 $1.82 Million - $2.74 Million	-371,551 Reduced 40.77%	539,732 $2.83 Million
Q3 2022 Nov 14, 2022	SELL	$0.8 - $8.85 $109,684 - $1.21 Million	-137,105 Reduced 13.08%	911,283 $6.38 Million
Q2 2022 Aug 15, 2022	SELL	$7.33 - $9.4 $2.33 Million - $2.99 Million	-318,316 Reduced 23.29%	1,048,388 $9.77 Million
Q1 2022 May 16, 2022	BUY	$7.97 - $9.85 $1.93 Million - $2.39 Million	242,474 Added 21.57%	1,366,704 $11.6 Million
Q4 2021 Feb 11, 2022	BUY	$8.85 - $10.42 $3.28 Million - $3.86 Million	370,618 Added 49.18%	1,124,230 $11 Million
Q3 2021 Nov 15, 2021	BUY	$9.25 - $10.76 $6.97 Million - $8.11 Million	753,612 New	753,612 $7.69 Million

195K

Ticker PROC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 112,824,000
Market Cap $196M
Description
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and ...

Get notified when there are updates to the investment portfolio of Compass Group LLC, based on Form 13F filings with the SEC.

Stay updated on Compass Group LLC with notifications on news.